| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Laboratory Medicine, University of Washington, Seattle, WA 98195;
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98104; and
Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201
HSV-1 inhibits apoptosis of infected cells, presumably to ensure that the infected cell survives long enough to allow completion of viral replication. Because cytotoxic lymphocytes kill their targets via the induction of apoptosis, protection from apoptosis could constitute a mechanism of immune evasion for HSV. Several HSV genes are involved in the inhibition of apoptosis, including Us5, which encodes glycoprotein J (gJ). Viruses deleted for Us5 showed defects in inhibition of caspase activation after Fas ligation or UV irradiation. Transfected cells expressing the Us5 gene product gJ were protected from Fas- or UV-induced apoptosis, as measured by morphology, caspase activation, membrane permeability changes, or mitochondrial transmembrane potential. In contrast, caspase 3 activation in mitochondria-free cell lysates by granzyme (gr)B was inhibited equivalently by Us5 deletion and rescue viruses, suggesting that gJ is not required for HSV to inhibition this process. However, mitochondria-free lysates from transfected cells expressing Us5/gJ were protected from grB-induced caspase activation, suggesting that Us5/gJ is sufficient to inhibit this process. Transfected cells expressing Us5/gJ were also protected from death induced by incubation with purified grB and perforin. These findings suggest that HSV has a comprehensive set of immune evasion functions that antagonize both Fas ligand- and grB-mediated pathways of CTL-induced apoptosis. The understanding of HSV effects on killing by CTL effector mechanisms may shed light on the incomplete control of HSV infections by the immune system and may allow more rational approaches to the development of immune modulatory treatments for HSV infection.
This article has been cited by other articles:
|
|
 |
|
  A. J. Johnson, C.-F. Chu, and G. N. Milligan Effector CD4+ T-Cell Involvement in Clearance of Infectious Herpes Simplex Virus Type 1 from Sensory Ganglia and Spinal Cords J. Virol., October 1, 2008; 82(19): 9678 - 9688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aubert, Z. Chen, R. Lang, C. H. Dang, C. Fowler, D. D. Sloan, and K. R. Jerome The Antiapoptotic Herpes Simplex Virus Glycoprotein J Localizes to Multiple Cellular Organelles and Induces Reactive Oxygen Species Formation J. Virol., January 15, 2008; 82(2): 617 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sloan and K. R. Jerome Herpes Simplex Virus Remodels T-Cell Receptor Signaling, Resulting in p38-Dependent Selective Synthesis of Interleukin-10 J. Virol., November 15, 2007; 81(22): 12504 - 12514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Benetti and B. Roizman In Transduced Cells, the US3 Protein Kinase of Herpes Simplex Virus 1 Precludes Activation and Induction of Apoptosis by Transfected Procaspase 3 J. Virol., October 1, 2007; 81(19): 10242 - 10248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Nguyen, R. M. Kraft, and J. A. Blaho Susceptibility of cancer cells to herpes simplex virus-dependent apoptosis J. Gen. Virol., July 1, 2007; 88(7): 1866 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Benetti and B. Roizman Protein Kinase B/Akt Is Present in Activated Form throughout the Entire Replicative Cycle of {Delta}US3 Mutant Virus but Only at Early Times after Infection with Wild-Type Herpes Simplex Virus 1. J. Virol., April 1, 2006; 80(7): 3341 - 3348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Sloan, J.-Y. Han, T. K. Sandifer, M. Stewart, A. J. Hinz, M. Yoon, D. C. Johnson, P. G. Spear, and K. R. Jerome Inhibition of TCR Signaling by Herpes Simplex Virus J. Immunol., February 1, 2006; 176(3): 1825 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hood, A. L. Cunningham, B. Slobedman, A. M. Arvin, M. H. Sommer, P. R. Kinchington, and A. Abendroth Varicella-Zoster Virus ORF63 Inhibits Apoptosis of Primary Human Neurons J. Virol., January 15, 2006; 80(2): 1025 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iannello, O. Debbeche, E. Martin, L. H. Attalah, S. Samarani, and A. Ahmad Viral strategies for evading antiviral cellular immune responses of the host J. Leukoc. Biol., January 1, 2006; 79(1): 16 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Dobbs, J. E. Strasser, C.-F. Chu, C. Chalk, and G. N. Milligan Clearance of Herpes Simplex Virus Type 2 by CD8+ T Cells Requires Gamma Interferon and either Perforin- or Fas-Mediated Cytolytic Mechanisms J. Virol., December 1, 2005; 79(23): 14546 - 14554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Loh, D. A. Thomas, P. A. Revell, T. J. Ley, and H. W. Virgin IV Granzymes and Caspase 3 Play Important Roles in Control of Gammaherpesvirus Latency J. Virol., November 15, 2004; 78(22): 12519 - 12528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Taddeo, W. Zhang, F. Lakeman, and B. Roizman Cells Lacking NF-{kappa}B or in Which NF-{kappa}B Is Not Activated Vary with Respect to Ability To Sustain Herpes Simplex Virus 1 Replication and Are Not Susceptible to Apoptosis Induced by a Replication-Incompetent Mutant Virus J. Virol., November 1, 2004; 78(21): 11615 - 11621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Benetti and B. Roizman Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis PNAS, June 22, 2004; 101(25): 9411 - 9416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sloan, G. Zahariadis, C. M. Posavad, N. T. Pate, S. J. Kussick, and K. R. Jerome CTL Are Inactivated by Herpes Simplex Virus-Infected Cells Expressing a Viral Protein Kinase J. Immunol., December 15, 2003; 171(12): 6733 - 6741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Peng, G. Henderson, G.-C. Perng, A. B. Nesburn, S. L. Wechsler, and C. Jones The Gene That Encodes the Herpes Simplex Virus Type 1 Latency-Associated Transcript Influences the Accumulation of Transcripts (Bcl-xL and Bcl-xS) That Encode Apoptotic Regulatory Proteins J. Virol., October 1, 2003; 77(19): 10714 - 10718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Medici, M. T. Sciortino, D. Perri, C. Amici, E. Avitabile, M. Ciotti, E. Balestrieri, E. De Smaele, G. Franzoso, and A. Mastino Protection by Herpes Simplex Virus Glycoprotein D against Fas-mediated Apoptosis: ROLE OF NUCLEAR FACTOR {kappa}B J. Biol. Chem., September 19, 2003; 278(38): 36059 - 36067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Benetti, J. Munger, and B. Roizman The Herpes Simplex Virus 1 US3 Protein Kinase Blocks Caspase-Dependent Double Cleavage and Activation of the Proapoptotic Protein BAD J. Virol., June 1, 2003; 77(11): 6567 - 6573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lovato, M. Inman, G. Henderson, A. Doster, and C. Jones Infection of Cattle with a Bovine Herpesvirus 1 Strain That Contains a Mutation in the Latency-Related Gene Leads to Increased Apoptosis in Trigeminal Ganglia during the Transition from Acute Infection to Latency J. Virol., April 15, 2003; 77(8): 4848 - 4857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jones Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency Clin. Microbiol. Rev., January 1, 2003; 16(1): 79 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Langelier, S. Bergeron, S. Chabaud, J. Lippens, C. Guilbault, A. M.-J. Sasseville, S. Denis, D. D. Mosser, and B. Massie The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation J. Gen. Virol., November 1, 2002; 83(11): 2779 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohsawa, D. H. Black, H. Sato, and R. Eberle Sequence and Genetic Arrangement of the US Region of the Monkey B Virus (Cercopithecine Herpesvirus 1) Genome and Comparison with the US Regions of Other Primate Herpesviruses J. Virol., February 1, 2002; 76(3): 1516 - 1520. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
